| Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial B Escudier, T Dorval, N Chaput, F André, MP Caby, S Novault, C Flament, ... Journal of translational medicine 3, 1-13, 2005 | 1333 | 2005 |
| Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial AMM Eggermont, S Suciu, M Santinami, A Testori, WHJ Kruit, J Marsden, ... The Lancet 372 (9633), 117-126, 2008 | 769 | 2008 |
| Cutaneous melanoma AMM Eggermont, A Spatz, C Robert The Lancet 383 (9919), 816-827, 2014 | 692 | 2014 |
| Cutaneous side-effects of kinase inhibitors and blocking antibodies C Robert, JC Soria, A Spatz, A Le Cesne, D Malka, P Pautier, J Wechsler, ... The lancet oncology 6 (7), 491-500, 2005 | 675 | 2005 |
| Gene expression profiling of primary cutaneous melanoma and clinical outcome V Winnepenninckx, V Lazar, S Michiels, P Dessen, M Stas, SR Alonso, ... Journal of the National Cancer Institute 98 (7), 472-482, 2006 | 548 | 2006 |
| Prevalence of p16 and CDK4 Germline Mutations in 48 Melanoma-Prone Families in France N Soufir, MF Avril, A Chompret, F Demenais, J Bombled, A Spatz, ... Human molecular genetics 7 (2), 209-216, 1998 | 464 | 1998 |
| Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guideline C Garbe, K Peris, A Hauschild, P Saiag, M Middleton, A Spatz, JJ Grob, ... European journal of cancer 46 (2), 270-283, 2010 | 414 | 2010 |
| Novel mode of action of c-kit tyrosine kinase inhibitors leading to NK cell–dependent antitumor effects C Borg, M Terme, J Taïeb, C Ménard, C Flament, C Robert, K Maruyama, ... The journal of clinical investigation 114 (3), 379-388, 2004 | 360 | 2004 |
| Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline–Update 2012 C Garbe, K Peris, A Hauschild, P Saiag, M Middleton, A Spatz, JJ Grob, ... European journal of cancer 48 (15), 2375-2390, 2012 | 354 | 2012 |
| Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma AMM Eggermont, S Suciu, A Testori, M Santinami, WHJ Kruit, J Marsden, ... Journal of clinical oncology 30 (31), 3810-3818, 2012 | 311 | 2012 |
| High expression of DNA repair pathways is associated with metastasis in melanoma patients A Kauffmann, F Rosselli, V Lazar, V Winnepenninckx, A Mansuet-Lupo, ... Oncogene 27 (5), 565-573, 2008 | 277 | 2008 |
| Prospective study of the cutaneous adverse effects of sorafenib, a novel multikinase inhibitor J Autier, B Escudier, J Wechsler, A Spatz, C Robert Archives of dermatology 144 (7), 886-892, 2008 | 268 | 2008 |
| Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991 AMM Eggermont, S Suciu, A Testori, WH Kruit, J Marsden, CJ Punt, ... European journal of cancer 48 (2), 218-225, 2012 | 259 | 2012 |
| Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032) PM Patel, S Suciu, L Mortier, WH Kruit, C Robert, D Schadendorf, ... European journal of cancer 47 (10), 1476-1483, 2011 | 259 | 2011 |
| Selection of immunostimulant AS15 for active immunization with MAGE-A3 protein: results of a randomized phase II study of the European Organisation for Research and Treatment … WHJ Kruit, S Suciu, B Dreno, L Mortier, C Robert, V Chiarion-Sileni, ... Journal of Clinical Oncology 31 (19), 2413-2420, 2013 | 235 | 2013 |
| Prognosis in patients with sentinel node–positive melanoma is accurately defined by the combined Rotterdam tumor load and Dewar topography criteria APT van der Ploeg, ACJ van Akkooi, P Rutkowski, ZI Nowecki, W Michej, ... Journal of clinical oncology 29 (16), 2206-2214, 2011 | 235 | 2011 |
| The development of optimal pathological assessment of sentinel lymph nodes for melanoma MG Cook, MA Green, B Anderson, AMM Eggermont, DJ Ruiter, A Spatz, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2003 | 226 | 2003 |
| Spitz tumors in children: a grading system for risk stratification A Spatz, E Calonje, S Handfield-Jones, RL Barnhill Archives of dermatology 135 (3), 282-285, 1999 | 220 | 1999 |
| X-chromosome genetics and human cancer A Spatz, C Borg, J Feunteun Nature Reviews Cancer 4 (8), 617-629, 2004 | 207 | 2004 |
| EANM-EORTC general recommendations for sentinel node diagnostics in melanoma AH Chakera, B Hesse, Z Burak, JR Ballinger, A Britten, C Caracò, ... European journal of nuclear medicine and molecular imaging 36, 1713-1742, 2009 | 201 | 2009 |
